These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Experimental studies in epilepsy: immunologic and inflammatory mechanisms. Legido A; Katsetos CD Semin Pediatr Neurol; 2014 Sep; 21(3):197-206. PubMed ID: 25510941 [TBL] [Abstract][Full Text] [Related]
26. Treatment of pediatric epilepsy: European expert opinion, 2007. Wheless JW; Clarke DF; Arzimanoglou A; Carpenter D Epileptic Disord; 2007 Dec; 9(4):353-412. PubMed ID: 18077226 [TBL] [Abstract][Full Text] [Related]
27. The role of inflammation in epilepsy. Vezzani A; French J; Bartfai T; Baram TZ Nat Rev Neurol; 2011 Jan; 7(1):31-40. PubMed ID: 21135885 [TBL] [Abstract][Full Text] [Related]
28. Seizure characteristics of epilepsy in childhood after acute encephalopathy with biphasic seizures and late reduced diffusion. Ito Y; Natsume J; Kidokoro H; Ishihara N; Azuma Y; Tsuji T; Okumura A; Kubota T; Ando N; Saitoh S; Miura K; Negoro T; Watanabe K; Kojima S Epilepsia; 2015 Aug; 56(8):1286-93. PubMed ID: 26118313 [TBL] [Abstract][Full Text] [Related]
29. Inflammation in pediatric epilepsies: Update on clinical features and treatment options. Granata T; Fusco L; Matricardi S; Tozzo A; Janigro D; Nabbout R Epilepsy Behav; 2022 Jun; 131(Pt B):107959. PubMed ID: 33867302 [TBL] [Abstract][Full Text] [Related]
30. [Implications of the International Classification of Seizures and Syndromes in the management of epilepsy]. Watanabe K Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):39-43. PubMed ID: 9134538 [TBL] [Abstract][Full Text] [Related]
36. Seizures and type 1 diabetes mellitus: current state of knowledge. Verrotti A; Scaparrotta A; Olivieri C; Chiarelli F Eur J Endocrinol; 2012 Dec; 167(6):749-58. PubMed ID: 22956556 [TBL] [Abstract][Full Text] [Related]
37. Value of autoantibodies for prediction of treatment response in patients with autoimmune epilepsy: review of the literature and suggestions for clinical management. Bien CG Epilepsia; 2013 May; 54 Suppl 2():48-55. PubMed ID: 23646971 [TBL] [Abstract][Full Text] [Related]
38. Epileptiform activity evoked by intracerebral injection of anti-brain antibodies. Mihailović LT; Cupić D Brain Res; 1971 Sep; 32(1):97-124. PubMed ID: 5000194 [No Abstract] [Full Text] [Related]
39. Serum antibodies in epilepsy and seizure-associated disorders. McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514 [TBL] [Abstract][Full Text] [Related]
40. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]